Lipopolysaccharide-binding protein and future Parkinson ’s disease risk: a European prospective cohort

Lipopolysaccharide (LPS) is the outer membrane component of Gram-negative bacteria. LPS-binding protein (LBP) is an acute-phase reactant that mediates immune responses triggered by LPS and has been used as a b...

Source: Journal of Neuroinflammation - July 21, 2023 Category: Neurology Authors: Yujia Zhao, Douglas I. Walker, Christina M. Lill, Bastiaan R. Bloem, Sirwan K. L. Darweesh, Brismar Pinto-Pacheco, Brooklyn McNeil, Gary W. Miller, Alicia K. Heath, Myrthe Frissen, Dafina Petrova, Maria-Jose S ánchez, María-Dolores Chirlaque, Marcela Gu Tags: Research Source Type: research